Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2023 Filed Feb 23, 2023 01:01 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
GrantStock Option (Right to Buy) · Derivative | 8,705 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005899 · doc4.xml · derivative · entry 2 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,705 Underlying: Common Stock · 8,705 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:01 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
GrantCommon Stock | 5,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005899 · doc4.xml · nonDerivative · entry 1 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,839 F1 · shares: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
DAMME LAURAVP, Clinical Affairs
|
GrantStock Option (Right to Buy) · Derivative | 8,705 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005897 · doc4.xml · derivative · entry 2 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,705 Underlying: Common Stock · 8,705 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
DAMME LAURAVP, Clinical Affairs
|
GrantCommon Stock | 5,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005897 · doc4.xml · nonDerivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,685 F1 · shares: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
Corcoran NicholasSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 19,732 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005896 · doc4.xml · derivative · entry 2 Corcoran Nicholas · CIK 0001964148 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,732 Underlying: Common Stock · 19,732 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
Corcoran NicholasSee Remarks
|
GrantCommon Stock | 12,886 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005896 · doc4.xml · nonDerivative · entry 1 Corcoran Nicholas · CIK 0001964148 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,886 F1 · shares: Includes 12,886 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
Gordon StephenChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,022 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005894 · doc4.xml · derivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,022 Underlying: Common Stock · 20,022 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC |
Gordon StephenChief Financial Officer
|
GrantCommon Stock | 13,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005894 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,789 F1 · shares: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,070 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,215 Underlying: Common Stock · 4,070 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 4,070 | $70.15 | $285,510.50 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:15 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,070 | $16.00 | $65,120.00 |
DisclosureSEC source: 0000899243-23-005254 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:06 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 2,173 | $70.08 | $152,283.84 |
DisclosureSEC source: 0000899243-23-005252 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,112 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.25, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:07 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 7,500 | $64.21 | $481,575.00 |
DisclosureSEC source: 0000899243-23-003884 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,285 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.00 to $64.60, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · derivative · entry 9 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,543 Underlying: Common Stock · 47 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,363 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · derivative · entry 8 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,887 Underlying: Common Stock · 1,363 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 214 | $65.81 | $14,083.34 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 139 | $64.88 | $9,018.32 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,334 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 96 | $64.04 | $6,147.84 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,473 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 379 | $62.52 | $23,695.08 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,569 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 582 | $62.00 | $36,084.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,948 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 47 | $38.46 | $1,807.62 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,363 | $16.14 | $21,998.82 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:06 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-003882 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,728 Underlying: Common Stock · 5,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:06 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 5,000 | $62.64 | $313,200.00 |
DisclosureSEC source: 0000899243-23-003882 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:06 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $16.14 | $80,700.00 |
DisclosureSEC source: 0000899243-23-003882 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,142 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,285 Underlying: Common Stock · 3,142 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 3,142 | $65.07 | $204,449.94 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.28, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:36 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,142 | $16.00 | $50,272.00 |
DisclosureSEC source: 0000899243-23-002668 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:40 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 900 | $66.12 | $59,508.00 |
DisclosureSEC source: 0000899243-23-002672 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,785 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:40 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 11,462 | $65.36 | $749,156.32 |
DisclosureSEC source: 0000899243-23-002672 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,685 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,558 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · derivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,427 Underlying: Common Stock · 5,558 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 5,558 | $65.21 | $362,437.18 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.56, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,558 | $16.00 | $88,928.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 23:12 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 6,332 | $65.19 | $412,783.08 |
DisclosureSEC source: 0000899243-23-002273 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,147 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.62, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,985 Underlying: Common Stock · 1,300 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 1,300 | $65.11 | $84,643.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:12 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,300 | $16.00 | $20,800.00 |
DisclosureSEC source: 0000899243-23-002272 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 23:12 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 1,306 | $65.09 | $85,007.54 |
DisclosureSEC source: 0000899243-23-002273 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,479 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:00 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 7,500 | $64.14 | $481,050.00 |
DisclosureSEC source: 0000899243-23-002076 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,785 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.00 to $64.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:02 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-002079 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,728 Underlying: Common Stock · 5,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:02 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 5,000 | $60.12 | $300,600.00 |
DisclosureSEC source: 0000899243-23-002079 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:02 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $16.14 | $80,700.00 |
DisclosureSEC source: 0000899243-23-002079 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · derivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,590 Underlying: Common Stock · 1,410 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 114 | $64.30 | $7,330.20 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.19 to $64.52, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 449 | $63.70 | $28,601.30 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.19 to $64.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 338 | $62.48 | $21,118.24 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,683 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.18 to $63.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 446 | $61.77 | $27,549.42 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,021 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.18 to $62.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 63 | $60.72 | $3,825.36 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,467 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.12 to $61.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,410 | $38.46 | $54,228.60 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,900 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,285 Underlying: Common Stock · 5,900 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.